Evaxion Biotech A/S (EVAX) News Today $2.45 -0.02 (-0.81%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$2.48 +0.03 (+1.22%) As of 01/31/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Evaxion Biotech Closes $10.8 Million Public Offering to Boost Vaccine DevelopmentJanuary 31 at 5:09 PM | tipranks.comEvaxion announces closing of $10.8 million public offeringJanuary 31 at 4:05 PM | globenewswire.comEvaxion Biotech stock slides after pricing $10.8M securities offeringJanuary 30 at 11:46 AM | msn.comEvaxion Biotech stock slides after pricing $10.8M securities offeringJanuary 30 at 11:46 AM | msn.comEvaxion Biotech prices 3.997M ADSs at $2.71 in public oferingJanuary 30 at 11:46 AM | markets.businessinsider.comEvaxion Biotech prices 3.997M ADSs at $2.71 in public oferingJanuary 30 at 11:46 AM | markets.businessinsider.comEvaxion Biotech stock hits 52-week low at $2.38 amid market challengesJanuary 30 at 11:46 AM | msn.comEvaxion Biotech stock hits 52-week low at $2.38 amid market challengesJanuary 30 at 11:46 AM | msn.comEvaxion announces pricing of $10.8 million public offeringJanuary 30 at 8:00 AM | globenewswire.comEvaxion Biotech granted 180-day compliance extension by NasdaqJanuary 28, 2025 | markets.businessinsider.comEvaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirementJanuary 28, 2025 | globenewswire.comEvaxion Biotech (NASDAQ:EVAX) Stock Quotes, Forecast and News SummaryJanuary 25, 2025 | benzinga.comEvaxion Biotech stock hits 52-week low at $3.06 amid sharp declineJanuary 17, 2025 | msn.comEvaxion Biotech: Evaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01January 16, 2025 | finanznachrichten.deEvaxion Biotech completes dosing in phase 2 trial with EVX-01January 16, 2025 | markets.businessinsider.comEvaxion concludes subject dosing in Phase II trial of melanoma vaccineJanuary 16, 2025 | finance.yahoo.comEvaxion Biotech Completes Dosing In Phase 2 Trial For Personalized Cancer Vaccine EVX-01January 16, 2025 | markets.businessinsider.comEvaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01January 15, 2025 | markets.businessinsider.comEvaxion announces completion of ADS ratio changeJanuary 14, 2025 | globenewswire.comEvaxion Biotech trading halted, news pendingJanuary 14, 2025 | markets.businessinsider.comEvaxion announces extension to January 14 of plan to implement ADS ratio changeJanuary 10, 2025 | markets.businessinsider.comEvaxion Biotech Amends ADS Ratio Change Effective DateJanuary 10, 2025 | tipranks.comEvaxion announces extension to January 14, 2025, of plan to implement ADS ratio changeJanuary 10, 2025 | globenewswire.comEvaxion Biotech Outlines Strategic Capital InitiativesJanuary 7, 2025 | tipranks.comEvaxion Biotech announces plan to implement ADS ratio changeDecember 30, 2024 | markets.businessinsider.comEvaxion announces plan to implement ADS ratio changeDecember 30, 2024 | globenewswire.comEvaxion Biotech (NASDAQ:EVAX) Stock, Short Interest ReportDecember 27, 2024 | benzinga.comEvaxion Biotech AS ADRDecember 26, 2024 | morningstar.comEvaxion Biotech pursues agreement with EIB to bolster equityDecember 17, 2024 | markets.businessinsider.comEvaxion Biotech: Evaxion establishes new AI-derived precision cancer vaccine conceptDecember 13, 2024 | finanznachrichten.deEvaxion Biotech establishes new Ai-derived precision cancer vaccine conceptDecember 13, 2024 | markets.businessinsider.comEvaxion establishes new AI-derived precision cancer vaccine conceptDecember 12, 2024 | markets.businessinsider.comEvaxion Biotech announces strategic milestones for 2025December 10, 2024 | markets.businessinsider.comEvaxion Biotech Unveils 2025 Strategic MilestonesDecember 10, 2024 | markets.businessinsider.comEvaxion announces 2025 milestones reflecting continued strong strategy executionDecember 9, 2024 | markets.businessinsider.comEvaxion Biotech Unveils Precision Cancer Vaccine BreakthroughDecember 3, 2024 | markets.businessinsider.comEvaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology CongressDecember 2, 2024 | markets.businessinsider.comEvaxion Biotech files to sell 5.25M American Depositary SharesNovember 19, 2024 | markets.businessinsider.comEvaxion appeals Nasdaq delisting determinationNovember 15, 2024 | uk.investing.comEvaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listingNovember 13, 2024 | finance.yahoo.comEvaxion Biotech: Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listingNovember 13, 2024 | finanznachrichten.deEvaxion Biotech receives, appeals delisting determination from NasdaqNovember 13, 2024 | markets.businessinsider.comEvaxion Biotech Appeals Nasdaq Delisting DecisionNovember 13, 2024 | markets.businessinsider.comEvaxion Biotech announces preclinical data for CMV vaccine program EVX-V1November 13, 2024 | markets.businessinsider.comEvaxion Biotech: Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1November 12, 2024 | finanznachrichten.deEvaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1November 12, 2024 | globenewswire.comEvaxion Biotech Shows Progress Amid Nasdaq ChallengesNovember 2, 2024 | markets.businessinsider.comEvaxion Biotech Reports Q3 Progress and FinancialsNovember 1, 2024 | markets.businessinsider.comEvaxion announces business update and third quarter 2024 financial resultsOctober 31, 2024 | globenewswire.comEvaxion Biotech to Announce Q3 Financial ResultsOctober 29, 2024 | markets.businessinsider.com Get Evaxion Biotech A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address EVAX Media Mentions By Week EVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVAX News Sentiment▼0.510.70▲Average Medical News Sentiment EVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVAX Articles This Week▼142▲EVAX Articles Average Week Get Evaxion Biotech A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies iBio News Today CytoMed Therapeutics News Today DURECT News Today Natural Alternatives International News Today Citius Pharmaceuticals News Today Traws Pharma News Today Lakeshore Biopharma News Today Pulmatrix News Today Cara Therapeutics News Today Equillium News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVAX) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
